AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power

Business Wire
04-14
  • Fourth quarter revenue of $37.4 million in line with preliminary expectations; fiscal 2025 revenue of $151.3 million comprised of 71% recurring revenue
  • Restructuring plan expected to deliver $3 million in annualized savings with 40% to be realized in fiscal 2026
  • Simplifying product portfolio; focused on higher growth higher margin products
  • Aerospace Test & Measurement segment ToughWriter printer transition 40% complete; drives operational efficiency and reduced working capital requirements while eliminating legacy royalties

WEST WARWICK, R.I., April 14, 2025--(BUSINESS WIRE)--AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, today announced financial results for its fiscal 2025 fourth quarter and full-year ended January 31, 2025. Results include the May 6, 2024 acquisition of MTEX NS.

Greg Woods, President and Chief Executive Officer of AstroNova, stated, "Fiscal 2025 was a challenging year as we addressed the difficult integration of MTEX, absorbed the impact of the Boeing strike and addressed the timing associated with large defense industry orders. Nonetheless, we aggressively implemented the AstroNova Operating System at MTEX, improved the leadership team, upgraded talent within the organization, and significantly improved the accounting and finance system and human resources processes. We are instilling accountability and discipline into the organization, streamlining the structure and eliminating waste. We have also identified how to best leverage MTEX’s operations in Portugal to create an AstroNova Center of Manufacturing Excellence in Europe. In fact, we are taking action throughout AstroNova to create a business that can deliver stronger earnings power."

"Importantly, we are leveraging the innovative foundation of MTEX technologies to create more competitive solutions that address an expanded range of applications and provide our customers with higher quality and reliability. This will also enable us to gain greater control over our supply chain in order to reduce costs and expand margins. We plan to launch new products incorporating our next-generation technology in the first quarter of fiscal 2026 and will be rolling out more products throughout the year."

Fiscal 2026 Outlook Reaffirmed

For fiscal 2026, AstroNova continues to expect net revenue in the range of $160 million to $165 million which is a 7% increase over fiscal 2025 at the mid-point of the range. Adjusted EBITDA margin is expected to be in the range of 8.5% to 9.5%, a 60-basis point expansion over the prior year at the mid-point.

Mr. Woods added, "We are focused on innovative solutions to gain market share and expand our market reach. Our strategic priorities in fiscal 2026 are to drive our print engine technology initiatives, capture greater ownership of the supply chain for our consumables, and drive the conversion to our ToughWriter family of printers with our Aerospace customers. In addition to offering a better solution for our customers, this conversion and other product simplification initiatives will reduce inventory, improve working capital and drive profitability."

Fourth Quarter Fiscal 2025 Overview

Net revenue for the fourth quarter of fiscal 2025 was $37.4 million compared with net revenue of $39.6 million for the fourth quarter of fiscal 2024, a decrease of 5.6% or $2.2 million, reflecting lower sales in both Product Identification (PI) and Test & Measurement (T&M) segments.

PI revenue was $25.7 million for the fourth quarter of fiscal 2025 compared with $26.6 million for the fourth quarter of fiscal 2024, a decrease of 3.6% or $0.9 million. The decrease was primarily attributable to less favorable product mix in the 2025 period, partially offset by the addition of MTEX, which the Company acquired in May 2024.

On a GAAP (Generally Accepted Accounting Principles) basis, PI segment operating loss was $11.2 million for the fourth quarter of fiscal 2025, which includes the previously announced non-cash goodwill impairment of $13.4 million largely associated with the Company’s MTEX business and $0.1 million in inventory step-up expenses. This compares with PI segment GAAP operating profit of $3.2 million, or 12.2% of segment revenue, for the fourth quarter of fiscal 2024, which includes $0.3 million in product retrofit costs and restructuring charges. On a non-GAAP basis, excluding the discrete expenses in both periods, PI segment operating profit was $2.3 million, or 8.9% of segment revenue in the fourth quarter of fiscal 2025, compared with segment operating profit of $3.0 million, or 11.1% of segment revenue, for the fourth quarter of fiscal 2024.

T&M segment revenue was $11.7 million for the fourth quarter of fiscal 2025 compared with $13.0 million for the fourth quarter of fiscal 2024, a decrease of 9.9% or $1.3 million. The decrease was due primarily to a delayed defense order and, to a lesser extent, deferred deliveries associated with the Boeing strike.

T&M segment operating profit was $2.3 million, or 20.0% of segment revenue, for the fourth quarter of fiscal 2025 compared with segment operating profit of $3.7 million, or 28.2% of segment revenue, for the fourth quarter of fiscal 2024.

GAAP gross profit was $12.7 million for the fourth quarter of fiscal 2025, resulting in a gross margin of 34.1%, compared with gross profit of $14.7 million and a gross profit of 37.2% for the same period in fiscal 2024, primarily reflecting lower revenue and less favorable product mix in the 2025 period.

GAAP operating loss for the fourth quarter of fiscal 2025 was $12.3 million, compared with GAAP operating income of $3.9 million for the fourth quarter of fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported operating income of $1.4 million, compared with $3.6 million in the fourth quarter of fiscal 2024.

Net loss on a GAAP basis was $15.6 million, or $2.07 per share, for the fourth quarter of fiscal 2025 compared with net income of $2.7 million, or $0.36 per diluted share, for the fourth quarter of fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported net income of $0.4 million, or $0.06 per diluted share, for the fourth quarter of fiscal 2025 compared with net income of $2.5 million, or $0.33 per diluted share, in the fourth quarter of fiscal 2024.

Adjusted EBITDA was $2.8 million for the fourth quarter of fiscal 2025 compared with Adjusted EBITDA $5.2 million for the fourth quarter of fiscal 2024.

The Company’s order backlog was $28.3 million as of January 31, 2025 compared with $31.4 million at the end of fiscal 2024.

Full-Year Fiscal 2025 Overview

Net revenue for fiscal 2025 was $151.3 million compared with net revenue of $148.1 million for fiscal 2024, an increase of 2.2% or $3.2 million, reflecting higher sales in the T&M segment, partially offset by lower sales in the PI segment.

PI revenue was $102.3 million for fiscal 2025 compared with $104.0 million for fiscal 2024, a decrease of 1.6% or $1.7 million. The decrease was primarily attributable to less favorable product mix in the 2025 period, partially offset by the addition of MTEX, which the Company acquired in May 2024.

On a GAAP (Generally Accepted Accounting Principles) basis, PI segment operating loss was $4.0 million for fiscal 2025, which includes the previously announced non-cash goodwill impairment of $13.4 million largely associated with the Company’s MTEX business and $0.2 million in inventory step-up expenses. This compares with PI segment GAAP operating profit of $10.1 million, or 9.7% of segment revenue, for fiscal 2024, which includes $3.2 million in product retrofit costs and restructuring charges. On a non-GAAP basis, excluding the discrete expenses in both periods, PI segment operating profit was $9.7 million, or 9.4% of segment revenue, for fiscal 2025, compared with segment operating profit of $13.2 million, or 12.7% of segment revenue, for fiscal 2024.

T&M segment revenue was $48.9 million for fiscal 2025 compared with $44.0 million fiscal 2024, an increase of 11.1% or $4.9 million. The increase primarily reflected higher revenue from supplies and service/other in the 2025 period, partly offset by lower hardware sales.

T&M segment operating profit was $11.1 million, or 22.8% of segment revenue, fiscal 2025 compared with segment operating profit of $10.2 million, or 23.2% of segment revenue, for fiscal 2024.

GAAP gross profit was $52.7 million for fiscal 2025, resulting in a gross margin of 34.9%, compared with gross profit of $51.6 million and a gross profit of 34.9% for fiscal 2024.

GAAP operating loss for fiscal 2025 was $8.6 million, compared with GAAP operating income of $8.8 million for fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported operating income of $6.6 million for fiscal 2025, compared with $12.0 million for fiscal 2024, primarily related to higher operating expenses in the 2025 period.

Net loss on a GAAP basis was $14.5 million, or $1.93 per share, for fiscal 2025 compared with net income of $4.7 million, or $0.63 per diluted share, for fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported net income of $2.7 million, or $0.33 per diluted share, in fiscal 2025 compared with net income of $7.2 million, or $0.97 per diluted share, in fiscal 2024.

Adjusted EBITDA was $12.3 million for fiscal 2025 compared with Adjusted EBITDA $17.6 million for fiscal 2024.

Amendment and Waiver of Credit Agreement

As previously disclosed, AstroNova obtained an amendment and waiver with regard to its credit agreement with Bank of America. Among other changes to the credit agreement, the amendment waives certain covered covenants as of the end of its fiscal quarter ended January 31, 2025, provides for relaxed financial covenant ratios during fiscal 2026, and provides for reduced payments of one of its term loans during fiscal 2026 as the Company implements its restructuring efforts, after which the payments of such term loan increase. The amended credit agreement provides for up to $2 million in add-backs to the Company’s Consolidated EBITDA (as defined in the credit agreement) for Company cash restructuring charges in fiscal 2026.

Earnings Conference Call Information

AstroNova will discuss its fiscal fourth-quarter and full-year fiscal 2025 financial results and business outlook in an investor conference call at 9:00 a.m. ET today. To access the conference call, please dial (833) 470-1428 (U.S. and Canada) or (404) 975-4839 (International) approximately 10 minutes prior to the start time and enter access code 957215.

A real-time and an archived audio webcast of the call will be available through the "Investors" section of the AstroNova website, https://investors.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, non-GAAP net income per diluted share, non-GAAP segment operating profit, and Adjusted EBITDA. AstroNova believes that the inclusion of these non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a non-GAAP basis. AstroNova’s management uses these non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the non-GAAP measures to the most directly comparable GAAP measures for the three and 12 months ended January 31, 2025 and 2024.

AstroNova has not reconciled the forward-looking Adjusted EBITDA growth percentage included in its fiscal 2026 financial targets and outlook to the most directly comparable forward-looking GAAP measure because this cannot be done without unreasonable effort due to the lack of predictability regarding cost of sales, operating expenses, depreciation and amortization, and stock-based compensation. The impact of any of these items, individually or in the aggregate, may be significant.

About AstroNova

AstroNova (Nasdaq: ALOT), a global leader in data visualization technologies since 1969, designs, manufactures, distributes and services a broad range of products that acquire, store, analyze, and present data in multiple formats.

The Product Identification segment provides a wide array of digital, end-to-end product marking and identification solutions, including hardware, software, and supplies for OEMs, commercial printers, and brand owners. The Test and Measurement segment provides products designed for airborne printing solutions, avionics, and data acquisition. Our aerospace products include flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. Our data acquisition systems are used in research and development, flight testing, missile and rocket telemetry production monitoring, power, and maintenance applications.

AstroNova is a member of the Russell Microcap® Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is available by visiting https://astronovainc.com/.

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words "believes," "expects," "intends," "plans," "anticipates," "likely," "continues," "may," "will," and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our organizational improvements at MTEX may not result in the benefits that we expect; (ii) the risk that our cost-reduction and product line rationalization initiative may not provide the expected benefits; (iii) the risk that our Aerospace customers may not convert to our ToughWriter line in the volumes or on the schedule that we expect; (iv) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (v) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

 
ASTRONOVA, INC.
Condensed Consolidated Statements of Income
In Thousands Except for Per Share Data
(Unaudited)
 
Three Months Ended
January 31,
2025
January 31,
2024
Net Revenue

$

37,361

$

39,594

Cost of Revenue

24,624

24,848

Gross Profit

12,737

14,746

Total Gross Profit Margin

34.1

%

37.2

%

Operating Expenses:
Selling & Marketing

6,421

5,977

Research & Development

1,751

1,878

General & Administrative

3,473

2,976

Goodwill Impairment

13,403

Total Operating Expenses

25,048

10,831

Operating Income (Loss)

(12,311

)

3,915

Total Operating Margin

(33.0

)%

9.9

%

Interest Expense

847

779

Other (Income)/Expense, net

100

(216

)

Income (Loss) Before Taxes

(13,258

)

3,352

Income Tax Provision

2,342

641

Net Income (Loss)

$

(15,600

)

$

2,711

Net Income (Loss) per Common Share - Basic

$

(2.07

)

$

0.36

Net Income (Loss) per Common Share - Diluted

$

(2.07

)

$

0.36

 
Weighted Average Number of Common Shares - Basic

7,534

7,438

Weighted Average Number of Common Shares - Diluted

7,534

7,550

 
 
Twelve Months Ended
January 31,
2025
January 31,
2024
Net Revenue

$

151,283

$

148,086

Cost of Revenue

98,534

96,465

Gross Profit

52,749

51,621

Total Gross Profit Margin

34.9

%

34.9

%

Operating Expenses:
Selling & Marketing

25,560

24,428

Research & Development

6,610

6,906

General & Administrative

15,816

11,491

Goodwill Impairment

13,403

Total Operating Expenses

61,389

42,825

Operating Income (Loss)

(8,640

)

8,796

Total Operating Margin

(5.7

)%

5.9

%

Interest Expense

3,210

2,697

Other (Income)/Expense, net

437

26

Income (Loss) Before Taxes

(12,287

)

6,073

Income Tax Provision

2,202

1,379

Net Income (Loss)

$

(14,489

)

$

4,694

Net Income (Loss) per Common Share - Basic

$

(1.93

)

$

0.63

Net Income (Loss) per Common Share - Diluted

$

(1.93

)

$

0.63

 
Weighted Average Number of Common Shares - Basic

7,509

7,415

Weighted Average Number of Common Shares - Diluted

7,509

7,496

 
...
ASTRONOVA, INC.
Consolidated Balance Sheets
In Thousands
(Unaudited)
 
January 31,
2025
January 31,
2024
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents

$

5,050

$

4,527

Accounts Receivable, net

21,218

23,056

Inventories, net

47,894

46,371

Prepaid Expenses and Other Current Assets

3,855

2,720

Total Current Assets

78,017

76,674

PROPERTY, PLANT AND EQUIPMENT

62,361

57,046

Less Accumulated Depreciation

(44,722

)

(42,861

)

Property, Plant and Equipment, net

17,639

14,185

OTHER ASSETS
Intangible Assets, net

23,519

18,836

Goodwill

14,515

14,633

Deferred Tax Assets

8,431

6,882

Right of Use Asset

1,781

603

Other Assets

1,694

1,438

TOTAL ASSETS

$

145,595

$

133,251

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable

$

7,928

$

8,068

Accrued Compensation

3,745

2,923

Other Liabilities and Accrued Expenses

4,461

2,706

Revolving Line of Credit

20,929

8,900

Current Portion of Long-Term Debt

6,110

2,842

Short-Term Debt

581

-

Current Portion of Royalty Obligation

1,358

1,700

Current Liability – Excess Royalty Payment Due

691

935

Income Taxes Payable

(0

)

349

Deferred Revenue

543

1,338

Total Current Liabilities

46,346

29,761

NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion

19,044

10,050

Royalty Obligation, net of current portion

1,106

2,093

Lease Liability, net of current portion

1,535

415

Grant Deferred Revenue

1,090

-

Income Tax Payables

684

551

Deferred Tax Liabilities

40

99

TOTAL LIABILITIES

69,845

42,969

SHAREHOLDERS’ EQUITY
Common Stock

547

541

Additional Paid-in Capital

64,215

62,684

Retained Earnings

49,380

63,869

Treasury Stock

(35,043

)

(34,593

)

Accumulated Other Comprehensive Loss, net of tax

(3,349

)

(2,219

)

TOTAL SHAREHOLDERS’ EQUITY

75,750

90,282

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

145,595

$

133,251

 
ASTRONOVA, INC.
Condensed Consolidated Statements of Cash Flows
(In Thousands)
(Unaudited)

Twelve Months Ended

January 31, 2025

January 31, 2024

Cash Flows from Operating Activities:
Net Income (Loss)

(14,489)

4,694

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and Amortization

4,780

4,266

Grant Income charged to Depreciation

159

Goodwill Impairment

13,403

Amortization of Debt Issuance Costs

30

23

Restructuring Cost

2,040

Share-Based Compensation

1,378

1,347

Deferred Income Tax provision (Benefit)

9

(78)

Changes in Assets and Liabilities, net of impact of acquisition:
Accounts Receivable

2,859

(1,486)

Inventories

1,616

2,910

Accounts Payable and Accrued Expenses

(2,379)

(46)

Deferred Revenue

(1,520)

-

Income Taxes

(904)

(343)

Other

(94)

(973)

Net Cash Provided by Operating Activities

4,848

12,354

 
Cash Flows from Investing Activities:
Purchases of Property, Plant and Equipment

(1,165)

(875)

Cash Paid for MTEX Acquisition, net of cash acquired

(19,109)

-

Net Cash Provided (Used) for Investing Activities

(20,274)

(875)

 
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans

13

105

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

146

107

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

(450)

(358)

Net Borrowings under Revolving Credit Facility

11,508

(7,000)

Proceeds from Long-Term Debt Borrowings

15,078

-

Payment of Minimum Guarantee Royalty Obligation

(1,902)

(1,725)

Principal Payments of Long-Term Debt

(8,980)

(2,100)

Payments of Debt Issuance Costs

(35)

-

Net Cash Provided (Used) for Financing Activities

15,378

(10,971)

 
Effect of Exchange Rate Changes on Cash and Cash Equivalents

571

73

Net Increase in Cash and Cash Equivalents

523

581

Cash and Cash Equivalents, Beginning of Period

4,527

3,946

Cash and Cash Equivalents, End of Period

5,050

4,527

 
Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for:
Cash Paid During the Period for Interest

2,701

2,343

Cash Paid During the Period for Income Taxes, net of refunds

2,210

1,694

Non-Cash Transactions:
Financed Equipment Purchase

822

Capital Lease Obtained in Exchange for Capital Lease Liabilities

1,581

 
ASTRONOVA, INC.
Revenue and Segment Operating Profit
In Thousands
(Unaudited)
 
Revenue Segment Operating Profit
Three Months Ended Three Months Ended
January 31,
2025
January 31,
2024
January 31,
2025
January 31,
2024
Product Identification

$

25,679

$

26,626

$

(11,174

)

$

3,239

Test & Measurement

11,683

12,968

2,337

3,652

Total

$

37,361

$

39,594

(8,837

)

6,891

General & Administrative Expenses

3,473

2,976

Operating Income (Loss)

(12,311

)

3,915

Interest Expense

847

779

Other (Income)/Expense, net

100

(216

)

Income (Loss) Before Income Taxes

(13,258

)

3,352

Income Tax Provision

2,342

641

Net Income (Loss)

$

(15,600

)

$

2,711

 
 
Revenue Segment Operating Profit
Twelve Months Ended Twelve Months Ended
January 31,
2025
January 31,
2024
January 31,
2025
January 31,
2024
Product Identification

$

102,345

$

104,041

$

(3,967

)

$

10,087

Test & Measurement

48,938

44,045

11,143

10,200

Total

$

151,283

$

148,086

7,176

20,287

General & Administrative Expenses

15,816

11,491

Operating Income (Loss)

(8,640

)

8,796

Interest Expense

3,210

2,697

Other (Income)/Expense, net

437

26

Income (Loss) Before Income Taxes

(12,287

)

6,073

Income Tax Provision

2,202

1,379

Net Income (Loss)

$

(14,489

)

$

4,694

 

Note: Segment Operating Profit excludes General & Administrative Expenses

 

ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP Items
In Thousands Except for Per Share Data
(Unaudited)
 
Three Months Ended
January 31,
2025
January 31,
2024
 
Gross Profit

$

12,737

$

14,746

Inventory Step-Up

62

-

Restructuring Charges, net

-

(32

)

Product Retrofit Costs, net

-

(210

)

Non-GAAP Gross Profit

$

12,799

$

14,504

 
Operating Expenses

$

25,048

$

10,831

MTEX-related Acquisition Expenses

(254

)

0

Restructuring Charges, net

-

43

Goodwill Impairment

(13,403

)

-

Non-GAAP Operating Expenses

$

11,392

$

10,874

 
Operating Income (Loss)

$

(12,311

)

$

3,915

MTEX-related Acquisition Expenses

254

(0

)

Inventory Step-Up

62

-

Restructuring Charges, net

-

(75

)

Product Retrofit Costs, net

-

(210

)

Goodwill Impairment

13,403

-

Non-GAAP Operating Income

$

1,408

$

3,630

 
Net Income (Loss)

$

(15,600

)

$

2,711

MTEX-related Acquisition Expenses, net

197

(0

)

CFO Transition Costs, net

(4

)

Inventory Step-Up, net

50

-

Restructuring Charges, net

-

(58

)

Product Retrofit Costs, net

-

(162

)

Goodwill Impairment

13,403

-

Tax Provision Valuation Allowance

2,373

Non-GAAP Net Income

$

419

$

2,491

 
Diluted Earnings Per Share

$

(2.07

)

$

0.36

MTEX-related Acquisition Expenses

0.03

(0.00

)

CFO Transition Costs, net

(0.00

)

-

Inventory Step-Up

0.01

-

Restructuring Charges, net

-

(0.01

)

Product Retrofit Costs, net

-

(0.02

)

Goodwill Impairment

1.78

-

Tax Provision Valuation Allowance

0.31

-

Non-GAAP Diluted Earnings Per Share

$

0.06

$

0.33

 
Twelve Months Ended
January 31,
2025
January 31,
2024
 
Gross Profit

$

52,749

$

51,621

Inventory Step-Up

216

-

Restructuring Charges

-

2,064

Product Retrofit Costs

-

642

Non-GAAP Gross Profit

$

52,966

$

54,327

 
Operating Expenses

$

61,389

$

42,825

MTEX-related Acquisition Expenses

(1,204

)

0

CFO Transition Costs

(432

)

Restructuring Charges

-

(512

)

Goodwill Impairment

(13,403

)

-

Non-GAAP Operating Expenses

$

46,350

$

42,313

 
Operating Income (Loss)

$

(8,640

)

$

8,796

MTEX-related Acquisition Expenses

1,204

(0

)

CFO Transition Costs

432

Inventory Step-Up

216

-

Restructuring Charges

-

2,576

Product Retrofit Costs

-

642

Goodwill Impairment

13,403

-

Non-GAAP Operating Income

$

6,615

$

12,014

 
Net Income (Loss)

$

(14,489

)

$

4,694

MTEX-related Acquisition Expenses, net

910

(0

)

CFO Transition Costs, net

328

-

Inventory Step-Up, net

161

-

Restructuring Charges, net

-

1,990

Product Retrofit Costs, net

-

496

Goodwill Impairment

13,403

-

Tax Provision

2,373

Non-GAAP Net Income

$

2,686

$

7,180

 
Diluted Earnings Per Share

$

(1.93

)

$

0.63

MTEX-related Acquisition Expenses

0.12

(0.00

)

CFO Transition Costs

0.04

-

Inventory Step-Up

0.02

-

Restructuring Charges

-

0.27

Product Retrofit Costs

-

0.07

Goodwill Impairment

1.76

-

Tax Provision Valuation Allowance

0.31

-

Non-GAAP Diluted Earnings Per Share

$

0.33

$

0.97

 
ASTRONOVA, INC.
Reconciliation of Net Income to Adjusted EBITDA
Amounts In Thousands
(Unaudited)
 
Three Months Ended
January 31, 2025 January 31, 2024
 
Net Income (Loss)

$

(15,600

)

$

2,711

Interest Expense

847

779

Income Tax Expense

2,342

641

Depreciation & Amortization

1,266

1,108

EBITDA

$

(11,146

)

$

5,239

Share-Based Compensation

219

282

MTEX-related Acquisition Expenses

259

-

CFO Transition Costs

(5

)

-

Inventory Step-Up

62

-

Goodwill Impairment

13,403

-

Restructuring Charges

-

(75

)

Product Retrofit Costs

-

(210

)

Adjusted EBITDA

$

2,793

$

5,236

 
Twelve Months Ended
January 31, 2025 January 31, 2024
 
Net Income (Loss)

$

(14,489

)

$

4,694

Interest Expense

3,210

2,697

Income Tax Expense (Benefit)

2,202

1,379

Depreciation & Amortization

4,780

4,266

EBITDA

$

(4,297

)

$

13,036

Share-Based Compensation

1,378

1,347

MTEX-related Acquisition Expenses

1,204

-

CFO Transition Costs

432

-

Inventory Step-Up

216

-

Goodwill Impairment

13,403

-

Restructuring Charges

-

2,576

Product Retrofit Costs

-

642

Adjusted EBITDA

$

12,336

$

17,601

 
ASTRONOVA, INC.
Reconciliation of Segment Operating Income to Non-GAAP Segment Operating Income
Amounts In Thousands
(Unaudited)
 
Three Months Ended
January 31, 2025 January 31, 2024
Product
Identification
Test &
Measurement
Total Product
Identification
Test &
Measurement
Total
 
Segment Operating Profit (Loss)

$

(11,174

)

$

2,337

$

(8,837

)

$

3,239

$

3,652

$

6,891

 
Inventory Step-Up

62

-

62

-

-

-

 
Restructuring Charges

-

-

-

(75

)

-

(75

)

 
Product Retrofit Costs

-

-

-

(210

)

-

(210

)

 
Goodwill Impairment

13,403

-

13,403

-

-

-

 
Non-GAAP - Segment Operating Profit

$

2,291

$

2,337

$

4,628

$

2,954

$

3,652

$

6,606

 
Twelve Months Ended
January 31, 2025 January 31, 2024
Product
Identification
Test &
Measurement
Total Product
Identification
Test &
Measurement
Total
 
Segment Operating Profit (Loss)

$

(3,967

)

$

11,143

$

7,176

$

10,087

$

10,200

$

20,287

 
Inventory Step-Up

216

-

216

-

-

-

 
Restructuring Charges

-

-

-

2,494

-

2,494

 
Product Retrofit Costs

-

-

-

642

-

642

 
Goodwill Impairment

13,403

-

13,403

-

-

-

 
Non-GAAP - Segment Operating Profit

$

9,652

$

11,143

$

20,795

$

13,223

$

10,200

$

23,423

 
Note: Segment Operating Profit excludes General & Administrative Expenses
 
ASTRONOVA, INC.
Reconciliation of GAAP to Non-GAAP Items for PI Segment
Amounts In Thousands
(Unaudited)
 
Three Months Ended January 31, 2025 Three Months Ended January 31, 2024
 
Total PI
Segment as
Reported

MTEX as
Reported
Inventory
Step-Up
Goodwill
Impairment
Adj MTEX (Non-
GAAP)
PI Excluding MTEX
(Non-GAAP)
Total PI
Segment as
Reported

Restructuring
Charges
Product
Retrofit
Costs

PI (Non-
GAAP)
Net Revenue

$

25,679

$

1,657

$

1,657

$

24,022

$

26,626

$

26,626

Cost of Revenue

17,108

1,313

(62

)

1,251

15,857

17,215

75

210

17,500

Gross Profit

8,571

344

62

-

406

8,165

9,411

(75

)

(210

)

9,126

Selling & Marketing

5,439

653

653

4,785

5,121

5,121

Research & Development

904

198

198

706

1,051

1,051

Goodwill Impairment

13,403

13,403

(13,403

)

-

-

-

-

Operating Expenses

19,746

14,254

-

(13,403

)

851

5,491

6,172

-

-

6,172

Segment Operating Profit (Loss)

$

(11,175

)

$

(13,910

)

$

62

$

13,403

$

(445

)

$

2,674

$

3,239

$

(75

)

$

(210

)

$

2,954

 
 
Twelve Months Ended January 31, 2025 Twelve Months Ended January 31, 2024
 
Total PI
Segment as
Reported

MTEX as
Reported
Inventory
Step-Up
Goodwill
Impairment
Adj MTEX (Non-
GAAP)
PI Excluding MTEX
(Non-GAAP)
Total PI
Segment as
Reported

Restructuring
Charges
Product
Retrofit
Costs

PI (Non-
GAAP)
Net Revenue

$

102,345

$

4,163

$

4,163

$

98,182

$

104,041

$

104,041

Cost of Revenue

68,420

3,652

(216

)

3,436

64,984

69,064

(2,494

)

(642

)

65,928

Gross Profit

33,925

511

216

-

727

33,198

34,977

2,494

642

38,113

Selling & Marketing

21,386

2,485

2,485

18,901

20,601

-

20,601

Research & Development

3,104

309

309

2,795

4,289

-

4,289

Goodwill Impairment

13,403

13,403

(13,403

)

-

-

0

-

0

Operating Expenses

37,892

16,197

-

(13,403

)

2,794

21,696

24,890

-

-

24,890

Segment Operating Profit (Loss)

$

(3,967

)

$

(15,686

)

$

216

$

13,403

$

(2,067

)

$

11,502

$

10,087

$

2,494

$

642

$

13,223

 
Note: Segment Operating Profit excludes General & Administrative Expenses. MTEX General & Administrative Expenses of $411,000 for the three months ended January 31, 2025 and $1,194,000 for the twelve months ended January 31, 2025 results in an MTEX Operating Profit (net of $13,403,000 Goodwill Impairment) of $995,000 for the three months ended January 31, 2025 and $3,478,000 for the twelve months ended January 31, 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250413216286/en/

Contacts

Tom DeByle
Vice President, Chief Financial Officer & Treasurer
AstroNova, Inc.
(401) 828-4000


Scott Solomon
Senior Vice President
Sharon Merrill Advisors
(857) 383-2409
ALOT@investorrelations.com



免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10